Eureka Therapeutics, Inc. - 29 Sep 2023 Form 3 Insider Report for Estrella Immunopharma, Inc. (ESLA)

Role
10%+ Owner
Signature
/s/ Emily Semon, as attorney-in-fact
Issuer symbol
ESLA
Transactions as of
29 Sep 2023
Transactions value $
$0
Form type
3
Filing time
10 Oct 2023, 16:15:15 UTC

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ESLA Common Stock 25.3M 29 Sep 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney.